Clinical Trial Update: Clinical Evidence Based and TCM Phenotype Group Study of Zhilong Huoxue Tongyu Capsule in the Treatment of Stable Angina Pectoris of Coronary Heart Disease (Qi Deficiency and Blood Stasis Syndrome) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Zhilong Huoxue Tongyu Capsule for stable angina in coronary artery disease; the study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Zhilong Huoxue Tongyu Capsule

Snippet

Sponsor: Jiang Hanmei | Conditions: Coronary Heart Disease (CHD) | Phase 2 | Status: UNKNOWN